Pembrolizumab: Solution concentrate for I.V. infusion 100 mg in 4 mL; keytruda® Page last updated: 19 July 2019 Public Summary Document (PSD) March 2019 PBAC Meeting - (PDF 706KB) Public Summary Document (PSD) March 2019 PBAC Meeting - (Word 181KB)